The Impact of Rhinoplasty Approach and Used Autologous Cartilage Grafts on the Nasal Skin-soft Tissue Envelope Metabolism
1 other identifier
observational
100
0 countries
N/A
Brief Summary
This is a prospective observation cohort investigation. Patients, that is participants, undergoing primary functional rhinoplasty will be evaluated in terms of measuring capillary blood lactic acid concentration in the nasal skin-soft tissue envelope immediately after the procedure and 7 days after the procedure. The aim of our study is to test whether or not different rhinoplasty approaches and volume of the used autologous cartilage grafts impact the nasal skin-soft tissue metabolism.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 22, 2024
CompletedFirst Posted
Study publicly available on registry
April 25, 2024
CompletedStudy Start
First participant enrolled
January 2, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 2, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2026
ExpectedApril 29, 2024
April 1, 2024
1 year
April 22, 2024
April 25, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Difference of capillary blood lactic acid concentration in the nasal skin-soft tissue envelope depending on the rhinoplasty approach
In participants undergoing primary functional rhinoplasty, the capillary blood lactic acid concentration from the skin-soft tissue envelope will be assessed by using Statstrip lactate measuring device and Statstrip test strips immediately after the procedure and 7 days after the procedure.
immediately after the surgical procedure and 7 days after the procedure
Correlation between the used autologous cartilage graft volume and lactic acid concentration in the nasal skin-soft tissue envelope
In the same participants undergoing different rhinoplasty approach, the volume of the used autologous cartilage grafts will be measured by using water displacement method, and this result will be correlated with the capillary blood lactic acid concentration from the skin-soft tissue envelope.
immediately after the surgical procedure and 7 days after the procedure
Study Arms (2)
Patients undergoing open rhinoplasty approach
Patients undergoing open rhinoplasty approach, of which most of will be augmented by using autologous cartilage grafts.
Patients undergoing closed approach rhinoplasty.
Patients undergoing closed approach rhinoplasty of which only few will be augmented by using autologous cartilage grafts.
Eligibility Criteria
All patients between 18 and 80 years of age, scheduled for primary functional rhinoplasty, who are willing to comply with the study and sign the informed consent, previously approved by the ethics commitee.
You may qualify if:
- Adult patients undergoing primary functional rhinoplasty who comply with the study
- Adult patients undergoing primary functional rhinoplasty who have singed the informed consent, previously approved by the ethics commitee.
You may not qualify if:
- patients with previous surgical procedures to the nose
- patients with greater previous injury or burns to the nasal skin
- patients with autoimmune skin conditions
- patients with significant cardiovascular diseases
- patients unwilling to comply with the study
- patients who do not want to sign the informed consent, previously approved by the ethics commitee.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- STUDY CHAIR
Marko Velimir Grgić, MD, PhD
UHC Sestre milosrdnice
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- medical doctor, resident
Study Record Dates
First Submitted
April 22, 2024
First Posted
April 25, 2024
Study Start
January 2, 2025
Primary Completion
January 2, 2026
Study Completion (Estimated)
September 1, 2026
Last Updated
April 29, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share
Individual participant data are not to be shared with other researchers.